Physician profile
Stephen J Epping
NPI 1821443565
$4,065.85
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.48 · 2020: $1,323 · 2021: $908 · 2022: $1,574 · 2023: $51.68 · 2024: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $821.46 | 2022-2024 | Apretude, Dovato |
| Astrazeneca Pharmaceuticals Lp | $733.42 | 2020-2022 | |
| Lilly USA, LLC | $329.95 | 2020-2022 | |
| Gilead Sciences, INC. | $322.05 | 2022 | |
| Amarin Pharma, INC. | $221.46 | 2020 | |
| Novo Nordisk INC | $214.80 | 2020-2021 | |
| Allergan, INC. | $206.85 | 2020 | |
| Glaxosmithkline, LLC. | $199.50 | 2019-2022 | |
| Lucid Diagnostics INC. | $151.54 | 2022 | |
| Genentech USA, INC. | $129.45 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.83 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $105.16 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.32 | 2020 | |
| Abbvie INC. | $75.23 | 2021-2022 | |
| Pfizer INC. | $51.18 | 2021-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37.19 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.51 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.28 | 2022 | |
| Sanofi-Aventis U.S. LLC | $25.03 | 2020-2021 | |
| Abbott Laboratories | $24.53 | 2021 | |
| Exact Sciences Corporation | $24.40 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.46 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $19.76 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $15.50 | 2021 | |
| Mylan Specialty L.P. | $15.14 | 2020 | |
| Boston Scientific Corporation | $14.82 | 2021 | |
| Corium, LLC | $14.72 | 2022 | |
| Sanofi Pasteur INC. | $13.66 | 2021 | |
| Dexcom, INC. | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Epping listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.